Literature DB >> 8317453

How good a marker is insulin level for insulin resistance?

M Laakso1.   

Abstract

Epidemiologic studies have correlated fasting and postload insulin levels with the risk of coronary heart disease, assuming that insulin levels are reliable markers of insulin resistance. However, this assumption has not been systematically studied. The author measured insulin response to an oral glucose load and quantitated insulin resistance using the euglycemic hyperinsulinemic clamp technique to evaluate the correlation between insulin level and the degree of insulin resistance in individuals with varying degrees of glucose tolerance. Subjects were randomly selected from previous population studies done in 1987-1989 at the Department of Medicine of the University of Kuopio in east Finland. Altogether, 50 subjects with normal glucose tolerance, 28 with impaired glucose tolerance, and 54 with non-insulin-dependent diabetes mellitus were studied. Correlations of insulin resistance (whole-body glucose uptake in clamp studies) with fasting or postload insulin levels were remarkably consistent, ranging from -0.58 to -0.74 (p < 0.01) in subjects with normoglycemia. In contrast, corresponding correlations were substantially weaker in subjects with impaired glucose tolerance and non-insulin-dependent diabetes. Among these subjects, only the fasting insulin level correlated significantly with insulin resistance (-0.47, p < 0.05 and -0.48, p < 0.01, respectively). The authors conclude that in population studies, only the fasting insulin level should be used as a marker of insulin resistance, particularly in subjects with abnormal glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317453     DOI: 10.1093/oxfordjournals.aje.a116768

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  97 in total

Review 1.  Strategies and prospects for finding insulin resistance genes.

Authors:  M P Stern
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Are ethnic differences in insulin sensitivity explained by variation in carbohydrate intake?

Authors:  V A Diaz; A G Mainous; R J Koopman; M E Geesey
Journal:  Diabetologia       Date:  2005-04-28       Impact factor: 10.122

3.  Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.

Authors:  Wolfgang Rathmann; Burkhard Haastert; Andrea Icks; Guido Giani; Jeffrey M Roseman
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 8.082

4.  Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease.

Authors:  Martin K Rutter; Peter W F Wilson; Lisa M Sullivan; Caroline S Fox; Ralph B D'Agostino; James B Meigs
Journal:  Circulation       Date:  2008-02-04       Impact factor: 29.690

5.  Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study.

Authors:  Jennifer Prescott; Ying Bao; Akila N Viswanathan; Edward L Giovannucci; Susan E Hankinson; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-23       Impact factor: 4.254

6.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI.

Authors:  T den Heijer; S E Vermeer; E J van Dijk; N D Prins; P J Koudstaal; A Hofman; M M B Breteler
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

7.  Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids.

Authors:  C D Byrne; N J Wareham; D C Brown; P M Clark; L J Cox; N E Day; C R Palmer; T W Wang; D R Williams; C N Hales
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

8.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 9.  Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Authors:  José Alejandro Luchsinger
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

10.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.